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ABSTRACT 
Background: Previous studies have shown that U.S. estimates of prediabetes or diabetes differ 
depending on test type, fasting plasma glucose (FPG) vs. hemoglobin A1c (HbA1c). Given age, 
race, and test differences reported in the literature, we sought to further examine these 
differences in prediabetes detection using a nationally representative sample.   
Methods: Using the National Health and Nutrition Examination Survey (NHANES) 1999 – 
2016, individuals were identified as having prediabetes with an HbA1c of 5.7 - 6.4% or a FPG of 
100 - 125 mg/dL. We excluded individuals with measurements in the diabetic range. We ran 
generalized estimating equation logistic regressions to examine the relationship between age, 
race, and test type with interactions, controlling for sex and BMI. We compared the difference in 
predicted prediabetes prevalence detected by impaired fasting glycemia (IFG) vs. HbA1c by 
race/ethnicity among children and adults separately using adjusted Wald tests.  
Results: The absolute difference in predicted prediabetes detected by IFG vs. HbA1c was 19.9% 
for white adolescents, 0% for black adolescents, and 20.1% for Hispanic adolescents; 21.4% for 
white adults, -1.2% for black adults, and 19.2% for Hispanic adults. Using adjusted Wald tests, 
we found the absolute differences between black vs. white and black vs. Hispanic individuals to 
be significant, but, not between Hispanic and white individuals among children and adults 
separately.  
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Conclusions: These observations highlight differences in test performance among racial/ethnic 
groups. Our findings corroborate the need for further studies to determine appropriate HbA1c 
cutoff levels for diagnosis of prediabetes by age group and race.  
Keywords: prediabetes, HbA1c, fasting plasma glucose, race, adolescents 
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INTRODUCTION 
In 2010, the American Diabetes Association (ADA) modified its guidelines to include 
hemoglobin A1c (HbA1c) as a diagnostic test for identifying children and adults with 
prediabetes and type 2 diabetes, based on its convenience as a non-fasting test.1 HbA1c is not a 
direct measure of glycemia, but represents the proportion of total hemoglobin with glucose 
attached to the N-terminal valine of the beta chain and therefore can be affected by factors 
independent of glycemia.2  
Previous epidemiologic studies have shown that HbA1c differs by age; even among 
individuals without diabetes and after adjusting for glucose levels, younger individuals have 
been shown to have 0.5% lower HbA1c compared with older individuals.3 Accordingly, studies 
in pediatric population demonstrated that HbA1c has lower sensitivity in children compared with 
adults given that the thresholds used for diagnosing prediabetes (5.7% - 6.4%) and diabetes 
(>6.5%) are the same over the lifespan.4-6 In addition to age, studies also documented differences 
in HbA1c by race/ethnicity with HbA1c levels that are 0.3-0.4% higher in black individuals 
compared with white individuals independent of glycemia, but screening thresholds are not race-
specific.7-9  
Previous studies have shown that U.S. estimates of prediabetes or diabetes differ 
depending on the test type (fasting plasma glucose (FPG) vs. HbA1c).10, 11 Given age, race, and 
test differences reported in the literature, we sought to examine differences in prediabetes 
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detection by test type, race/ethnicity among children and among adults separately using a 
nationally representative sample.   
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METHODS 
We used the National Health and Nutrition Examination Survey (NHANES) from 1999 – 
2016, which is a cross-sectional, nationally representative examination study of the United States 
civilian non-institutionalized population.12 We were focused on prediabetes as an outcome for 
this analysis due to the small number of individuals with diabetes in the pediatric population. 
In NHANES, participants visit a mobile examination center where medical, dental, and 
physiological measurements and laboratory tests are performed by trained medical personnel.10 
All individuals had a HbA1c level drawn and a subset (morning session) were invited to provide 
a FPG sample after verification of fasting status.13 Individuals who use medications for diabetes 
are excluded from the FPG measurement. HbA1c assays were performed on whole blood using 
the Tosoh Automated Glycohemoglobin Analyzer HLC-723G8.14   
NHANES uses a stratified multistage probability sampling design, oversampling 
adolescents aged 12–19 years, non- Hispanic blacks, and Mexican Americans to provide reliable 
statistical estimates for these subpopulations. We used the sample weights for the FPG, which 
accounts for the additional probability of selection into the subsample component and provides 
nationally representative estimates for the population studied.15  
Based on ADA criteria, individuals were identified as having prediabetes with HbA1c of 
5.7 - 6.4% or FPG of 100 - 125 mg/dL.1 We therefore excluded individuals who had 
measurements in the diabetic range. Normal weight was defined as BMI <85th percentile 
(children) or BMI <25 kg/m2 (adults), overweight as BMI ≥85th and <95th percentile (children) or 
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BMI ≥25 and <30 kg/m2 (adults), and obese as BMI ≥95th percentile (children) or BMI≥30 kg/m2 
(adults). 
We generated a long dataset in which each individual’s test result (HbA1c and FPG) were 
represented as separate observations. We ran generalized estimating equation logistic regressions 
to examine the relationship between age, race, and test type with interactions, controlling for sex 
and BMI. We conducted Chi square tests to examine the association between race/ethnicity and 
demographic characteristics (sex and weight status) for each age group. Because we found a 
significant three-way interaction, we calculated predicted prediabetes proportions for all 
combinations of test type, race, and age group. We then compared the difference in predicted 
prediabetes detected by impaired fasting glucose (IFG) vs. HbA1c by race/ethnicity among 
children and adults separately, using adjusted Wald tests. We used a Bonferroni correction of 
p<0.008 to determine statistical significance. We note that differences in test type by sex and 
weight status were not the focus of this study. As a result, sex and weight status were included as 
covariates in the analyses, but, were not key variables of interest. Because “other” race 
represents a variety of races, we included these individuals in the dataset but did not perform 
statistical comparisons for that race group. Statistical analyses were performed with Stata 
software version 15.  
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RESULTS 
Figure 1 shows inclusion and exclusion criteria. Table 1 shows the demographic 
characteristics and the overall breakdown of prediabetes status for the population. Figure 2 
shows the predicted prediabetes proportion according to age group, race and test type. For 
example, the prevalence of prediabetes in white adolescents 12-17 years detected by FPG was 
22.4% vs. 2.4% for HbA1c; whereas the prevalence of prediabetes in black adults detected by 
FPG was 26.3% vs. 27.5% for HbA1c. We observed larger differences in predicted prediabetes 
by test type (IFG vs. HbA1c) among Hispanics and non-Hispanic whites while there was little 
difference in prediabetes identified by FPG as compared to HbA1c among non-Hispanic blacks. 
(Figure 2).  
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DISCUSSION 
The lack of a significant difference in rates of predicted prediabetes detected by IFG vs. 
HbA1c (IFG - HbA1c) among U.S. black children and adults indicates that there are comparable 
rates of prediabetes detection with either test type. This is in contrast to what we found for white 
and Hispanic adolescents and adults, for whom there were significant differences in the rates of 
prediabetes detected by IFG vs. HbA1c (IFG - HbA1c), with much lower estimates using HbA1c 
vs. FPG. Our findings are consistent with previous studies that have evaluated the prevalence of 
prediabetes by race.8.   
Menke et al described the prevalence of prediabetes for individuals in NHANES who had 
FPG, HbA1c, and 2 hour oral glucose tolerance tests performed.10 They reported estimates of 
29.8% by FPG vs. 19.3% by HbA1c among U.S. white adults and 20.7% by FPG and 26.4% by 
HbA1c among U.S. black adults. Andes performed a similar study but focused on children (12-
18 years) and young adults (19-34 years).11 They reported estimates of 12.4% by FPG vs. 2.3% 
by HbA1c among U.S. white young adults, and 9.7% by FPG vs. 1.7% by HbA1c among U.S. 
white adolescents; 10.7% by FPG vs. 18.2% by HbA1c among U.S. black young adults, and 
7.8% by FPG vs. 16.7% by HbA1c among U.S. black adolescents. Our estimates of prediabetes 
differ from those of Menke and Andes as there were differences in the samples, but there are 
clear differences in test performance across the race categories.  
HbA1c is a recommended diagnostic test for prediabetes and type 2 diabetes for the 
pediatric population,2 and longitudinal studies have shown that prediabetes status in childhood is 
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associated with an increased risk of type 2 diabetes later in life. Vijayakumar followed a group of 
American Indian children and adolescents longitudinally over a period of 42 years, and found 
that children with prediabetes based on ADA criteria, or a 2-hour PG (140–199 mg/dL), had a 
higher incidence of diabetes compared with children who did not have prediabetes.4 They did 
however note a lower sensitivity for the HbA1c threshold of 5.7% (8% in boys and 19% in girls) 
and therefore suggested a lower threshold of 5.4% to identify a greater number of children. Our 
findings corroborate the need for further studies to help determine appropriate HbA1c cutoff 
levels for diagnosis of prediabetes by age group and race.  
We recognize that the HbA1c test’s convenience as a non-fasting test has the potential to 
improve screening rates in youth at risk of developing type 2 diabetes. However, it is critical that 
pediatricians using the test understand its opportunities and limitations. Kelsey et al studied 
children aged 11-13 years in the HEALTHY study, a school-based intervention focused on 
diabetes risk factors in youth at-risk for dysglycemia.16 They measured HbA1c in the populations 
of children studied and described a shift in the HbA1c distribution curve to the right in black 
youth compared with white or Hispanic children; 7.1% of normal weight black children had an 
HbA1c ≥ 5.7 compared with only 1.3% of Hispanic and 0.1% of white children. They suggested 
that the “interpretation of prediabetes range HbA1c should be done with caution”, particularly 
given that of the 128 sixth graders in the HEALTHY cohort who had “prediabetes”, only one 
progressed to diabetes and 53 had a normal HbA1c in the eighth grade.16 We agree with this 
caution given the race/ethnicity differences in detection by FPG vs. HbA1c for black individuals 
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compared with other races. More longitudinal studies are needed to understand whether there are 
differential long-term risks of prediabetes by age group, race, and test type.   
We acknowledge limitations of our study including the cross-sectional study design, the 
use of FPG as a gold standard (2 hour oral glucose tolerance test might be considered the gold 
standard which was not performed here), the classification based on one blood draw, and the 
definitions of prediabetes are based originally on adult data. We elected to use the age categories 
of 12-17 years vs. ≥18 years to allow for comparison across the literature. We recognize that the 
mechanism of T2D in young adults may be more similar to children compared with older adults, 
but the diagnostic criteria do not differ across the adult population. We acknowledge that FPG 
has higher sensitivity and lower reproducibility compared with HbA1c.17 It is also possible that 
youth are less likely to follow the fasting protocol than adults, although participants were asked 
about their food intake before the fasting samples were drawn. NHANES does not have data on 
non-glycemic factors that alter HbA1c measurements, such as disorders that affect blood cell 
turnover, hemoglobinopathies, and medications. Furthermore, NHANES does not provide 
information about pubertal staging, which is a known period of insulin resistance. We 
acknowledge differences between our findings and the Menke and Andes papers may be 
attributed to the difference in sampling demographics and objectives. The objective of our study 
was unique, as we were unaware of studies that have focused on differences in prediabetes 
detection rates by test type, age, race/ethnicity using a nationally representative sample.  
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Our findings are relevant for informing studies of epidemiologic burden and trends for 
prediabetes in youth, particularly as it relates to racial differences in diabetes risk. Studies like 
the SEARCH for Diabetes in Youth Study have shown that minority youth are at elevated risk 
for type 2 diabetes.18 Our study reveals that racial differences in diabetes risk may be impacted 
by test type, which gains even more relevance as an increasing number of pediatricians are 
ordering HbA1c in accordance with the ADA guidelines.19 Will increasing use of HbA1c lead to 
overdiagnosis of diabetes risk in minority children, (given known non-glycemic racial 
differences in HbA1c) or appropriate identification of a population at high risk for developing 
diabetes, and what will be the impact on healthcare delivery and health outcomes? Additional 
longitudinal studies are needed to assess the ability of different screening tests to predict later 
development of diabetes, both in the healthcare delivery system as well as in population-based 
cohorts.  
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Figure 1. Study Sample Flow Diagram 
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 Children, 12-17 years (n = 4651)† 
Weighted % (n) 
Adults, ≥18 years (n = 17302)† 
Weighted % (n) 
Race/Ethnicity Overall  
(n = 4651) 
NH White  
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NH Black 
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(n = 1729) 
Other 
(n = 347) 
 Overall 
(n = 17302) 
NH White 
(n = 7935) 
NH Black 
(n = 3378) 
Hispanic 
(n = 4582) 
Other 
(n = 1407) 
 











































Weight Statusǂ      P = 0.0001      P = 0.0001 































































Glucose Status      
Impaired fasting 

















Table 1. Characteristics of Study Sample by Age and Race/Ethnicity Category, NHANES 1999 – 2016 
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(†) No. of subjects within each age group may not sum to equal the total due to missing data. 
(ǂ) Weight status was defined by body mass index, calculated as weight in kilograms divided by height in meters squared. The U.S. Centers and Disease Control 
and Prevention (CDC) growth chart was used for children 12-17 years: normal/underweight was defined as less than 85th percentile; overweight, from 85th to 
less than 95th percentile; and obese, 95th percentile and higher. Standard BMI cutoffs were used for adults: normal weight, <25 kg/m2; overweight, 25-29.9 
kg/m2; obese, ≥30 kg/m2. 
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Figure 2a. Estimates of the Proportion of Prediabetes by IFG and HbA1c by Race/Ethnicity and 
Test Type, for Children 12-17 Years and Adults 18+ Years.  
Solid white = Hispanic based on impaired fasting glucose; dots = Hispanic based on HbA1c; 
solid gray = White non-Hispanic based on impaired fasting glucose; striped gray = White non-
Hispanic based on HbA1c; solid black = Black non-Hispanic based on impaired fasting glucose; 
striped black = Black non-Hispanic based on HbA1c.  
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Figure 2b. Difference in Prediabetes Prevalence (Fasting Plasma Glucose – HbA1c) by Test 
Type, Race Among Children, 12-17 years 
 
 
*Comparison of white NH vs. black NH (p=0.0004); Hispanic vs black NH (p=0.0004); white 
NH vs. Hispanic (p=0.017) 
 
 
Figure 2c. Difference in Prediabetes Prevalence (Fasting Plasma Glucose – HbA1c) by Test 
Type, Race Among Adults 
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*Comparison of white NH vs. black NH (p=0.0004); Hispanic vs. black NH (p=0.0004); white 
NH vs. Hispanic (p=0.02) 
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